Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aline Talhouk

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 2, 2023
Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing ProtocolAline Talhouk, Amy Jamieson, Emma J Crosbie, et al.
Scientific Reports|January 19, 2025
Quantifying intratumoral biomarker heterogeneity in tubo-ovarian high-grade serous carcinoma to optimize clinical translationAline Talhouk, Derek S Chiu, Liliane Meunier, et al.
Pain|February 26, 2026
Endometriosis pain index: development of a model to predict poor pain-related quality of life after endometriosis surgery through machine learning analysis of registry dataDwayne R Tucker, Brie Dungate, Derek S Chiu, et al.
Journal of Clinical Medicine|August 10, 2024
Prognostic Significance of Disseminated Tumor Cells in Bone Marrow for Endometrial Carcinoma PatientsLéa Louise Volmer, Marcel Grube, Annika Rohner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for ImmunotherapyCharlotte S Lo, Sanaz Sanii, David R Kroeger, et al.
Gynecologic Oncology|June 15, 2023
Harmonized molecular classification; assessment of a single-test ProMisE NGS toolAmy Jamieson, Melissa K McConechy, Amy Lum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2020
FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular SubtypesAsmerom T Sengal, Ann-Marie Patch, Cameron E Snell, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 3, 2026
The Progesterone Challenge Test as a Functional Biomarker of Endometrial Cancer Risk: Results from a Prospective Feasibility StudyAndrea Neilson, Rachel Woima, Dollina Dodani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2016
Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable PrognosisMelissa K McConechy, Aline Talhouk, Samuel Leung, et al.
Histopathology|December 17, 2024
Papillary and ductal patterns of mesonephric-like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomasArdalan Akbari, Jennifer Pors, Amy Lum, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 2, 2023
Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing ProtocolAline Talhouk, Amy Jamieson, Emma J Crosbie, et al.
Scientific Reports|January 19, 2025
Quantifying intratumoral biomarker heterogeneity in tubo-ovarian high-grade serous carcinoma to optimize clinical translationAline Talhouk, Derek S Chiu, Liliane Meunier, et al.
Pain|February 26, 2026
Endometriosis pain index: development of a model to predict poor pain-related quality of life after endometriosis surgery through machine learning analysis of registry dataDwayne R Tucker, Brie Dungate, Derek S Chiu, et al.
Journal of Clinical Medicine|August 10, 2024
Prognostic Significance of Disseminated Tumor Cells in Bone Marrow for Endometrial Carcinoma PatientsLéa Louise Volmer, Marcel Grube, Annika Rohner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for ImmunotherapyCharlotte S Lo, Sanaz Sanii, David R Kroeger, et al.
Gynecologic Oncology|June 15, 2023
Harmonized molecular classification; assessment of a single-test ProMisE NGS toolAmy Jamieson, Melissa K McConechy, Amy Lum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2020
FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular SubtypesAsmerom T Sengal, Ann-Marie Patch, Cameron E Snell, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 3, 2026
The Progesterone Challenge Test as a Functional Biomarker of Endometrial Cancer Risk: Results from a Prospective Feasibility StudyAndrea Neilson, Rachel Woima, Dollina Dodani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2016
Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable PrognosisMelissa K McConechy, Aline Talhouk, Samuel Leung, et al.
Histopathology|December 17, 2024
Papillary and ductal patterns of mesonephric-like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomasArdalan Akbari, Jennifer Pors, Amy Lum, et al.
Pageof 10